20
Participants
Start Date
January 15, 2024
Primary Completion Date
February 25, 2024
Study Completion Date
July 31, 2024
Active Comparator: Study Group A: Blis Q24 Serum at higher dose
Active Comparator: Study Group A: Blis Q24 Serum at 1e8 cfu/ dose (Active)
Active Comparator: Study Group B: Blis Q24 Serum at lower dose
Active Comparator: Study Group A: Blis Q24 Serum at 1e6 cfu/ dose (Active)
Blis Technologies Ltd, Dunedin
Lead Sponsor
BLIS Technologies Limited
INDUSTRY